• Home
  • About Steve Woodruff
  • Contact
  • About Impactiviti

Impactiviti blog

Pharma needs? Ask Steve.

Feeds:
Posts
Comments
« GlaxoSmithKline, Avandia, and Lawyers
Global Avandia Lawsuit – “We’re in it to Win it!” says Firm »

Pharma Web Branding, Part 2 – GlaxoSmithKline

May 22, 2007 by Steve Woodruff

In my continuing series on how pharmaceutical companies engage the public with their brand on their website homepages, this week we’ll take a look at GlaxoSmithKline‘s home page, http://www.gsk.com (last week was Pfizer’s turn!)

gsk-logo.jpgGlaxo became a Top-5 pharma company through a merger strategy. SmithKline Beecham joined Glaxo Wellcome to create…well, you know the tale. Merger mouthful. Most people now find it easier to refer to the company as “Glaxo” or as “GSK” – my bias is well-known about munging together a bunch of legacy names to come up with a run-on-sentence for a name.

And, I will admit, that when the merger occurred and the new GSK logo was unveiled, I found it to be an underwhelming moment in marketing. My first impression: an orange guitar pick. And to this day, that is all I see.

Turning to the public website, in the browser title bar we see this tagline: “Improving health and quality of life.” As with so many pharma companies, absolutely bland, obvious, and non-distinguishing. That phrase could be used about bottled water, vitamins, exercise machines, and a book on therapeutic massage. Sigh.

Nonetheless, the website itself has some reasonably engaging design features. Unlike Pfizer’s, panned last week for trying to say too much, the current GSK site presents a compelling “story” front-and-center: The Menace of Malaria. The two brief blurbs, with accompanying graphics (the mosquito is very effective), draw the reader in to explore further. By focusing on ONE thing that GSK is actively working on, the site makes it easier to dig in.

Of necessity, for a major pharmaceutical company, there are many links and potential destinations, and this site does a pretty good job using smaller navigational areas to direct the users to various areas of interest. The drop-down boxes toward the bottom right are a particularly effective way to give choices without an overwhelming, in-your-face list. Since there are so many choices, it might be a good idea to use simple rollover technology to provide brief snippets of information when people mouse-over the menu items (for instance, why would I want to take the survey?)

Below the graphic shown here are some other helpful links, including recent news releases, Quick Links, up-to-the-minute stock prices, and an RSS feed for newsreaders (every company should be doing this nowadays).

Yes, the site is a bit busy, and the type quite small in many places, but for a company this size, it’s difficult to know what to leave out on the home page. GSK has done an admirable job making a large amount of information accessible without it being overwhelming.

About these ads

Share this:

  • Twitter
  • StumbleUpon
  • Facebook
  • Email

Like this:

Like Loading...

Posted in Business, Communications, Glaxosmithkline, GSK, Marketing, Pharma, Pharmaceutical, Web | 7 Comments

7 Responses

  1. on May 22, 2007 at 1:36 pm Lewis Green

    Steve,

    I be curious to know who you think GSK designed the web site for and to whom the messages are aimed? Who makes up their audiences? Doctors? Pharmacists? Hospital Administrators?

    Does anyone actually visit a pharmaceutical company’s web site? Having a number of health care clients, I have a tough time imagining the doctors spending much, if any time online.

    I am really interested in your take? I have never served a pharmaceutical company so am not informed regarding their audiences.


  2. on May 23, 2007 at 5:58 am impactiviti

    Lewis,

    These companies have the difficult challenge of having to address the following, through one site:

    - Global audiences (usually have sub-sites for this; some drugs, for instance, are approved in one country but not another)
    - Doctors (often they set up Health Care Professionals only sub-sites)
    - Patients
    - Investors/General Public
    - Employees/potential employees
    - Regulators (who sniff around for any hint of “off-label” promotion)

    Having done a good bit of high-level information/interface design for the web, I can assure you that this is no simple task when you have this number and diversity of interest parties! However, it still doesn’t excuse a design that is non-engaging…


  3. on January 26, 2008 at 9:49 am Pharma Web Branding, Part 7 - Abbott « Impactiviti blog

    [...] GSK [...]


  4. on January 26, 2008 at 12:15 pm Pharma Web Branding, Part 7 - Abbott « StickyFigure

    [...] GSK [...]


  5. on February 2, 2008 at 10:09 am Pharma Web Branding, Part 8 - BMS « Impactiviti blog

    [...] GSK [...]


  6. on March 6, 2008 at 2:42 am Pharma Web Branding, Part 11 - Genentech « Impactiviti blog

    [...] GSK [...]


  7. on March 20, 2008 at 9:15 am Au Pair

    very nice web site. My English is not so good, so I do not understandt it well, but it seems very good. Thanks



Comments are closed.

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
    Pharmaceutical Connection Agent
  • Connect with Steve Woodruff


    SteveWoodruff.com
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Free ebook! Getting Started with Social Networking

  • Subscribe!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Subscribe to our e-newsletter

    View our Archive
    Email Marketing by Constant Contact®

  • Bookmark



  • Recent Posts

    • Is Pharma Sales Dead?
    • We Do Everything…Just Like Everybody Else!
    • Create Your Vendor Map
    • Create Your Vendor Funnel
    • Friday Notes 3_8_13
    • Fresh Job Postings
    • On Writing Well
    • Let’s Talk
    • Successful Vendor Management – Measuring Success
    • Successful Vendor Management – Define Your Terms
  • Recent Comments

    Glen Drummond on Is Pharma Sales Dead?
    Andrew Nemiccolo (@n… on Is Pharma Sales Dead?
    DenVan on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
  • Archives

    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
  • Categories

    • Abbott
    • Advertising
    • After Hours
    • Allergan
    • Amgen
    • Amylin
    • Assessment
    • AstraZeneca
    • Avandia
    • Bayer
    • Biotech
    • Blogging
    • Blogs
    • BMS
    • Boehringer Ingelheim
    • book review
    • Branding
    • Bristol Myers
    • Business
    • Career planning
    • Celgene
    • Cephalon
    • Communications
    • Conference
    • Consulting
    • Covidien
    • Daiichi Sankyo
    • Depression
    • Diabetes
    • DTC
    • eLearning
    • Eli Lilly
    • Entrepreneur
    • ePatients
    • epharma
    • Ethics
    • facebook
    • FDA
    • Forest Labs
    • Friday Collection
    • Fun
    • Genentech
    • Genzyme
    • Glaxosmithkline
    • GSK
    • Healthcare
    • Impactiviti
    • Inspiration
    • Interview
    • iPad
    • J&J
    • Job
    • Job Board
    • John Mack
    • Johnson and Johnson
    • Lilly
    • Marketing
    • Medical Devices
    • Medicine
    • Meetings
    • Merck
    • Mobile
    • Music
    • Musings
    • Networking
    • News
    • No Bad Training
    • Novartis
    • Novo Nordisk
    • Obesity
    • Oncology
    • Outsourcing
    • Parenting
    • Paul Potts
    • Personal
    • Peter Rost
    • Pfizer
    • Pharma
    • Pharma News
    • Pharmaceutical
    • Project Management
    • Purdue
    • Recommendations
    • Red Cross
    • Reviews
    • Right-sourcing
    • Roche
    • Sales
    • Sales training
    • Sanofi-Aventis
    • Scandal
    • Schering
    • Social Media
    • SPBT
    • Spoof
    • Starting a business
    • Statins
    • Takeda
    • Technology
    • The Pharma Side
    • Top News
    • Training
    • Training Needs
    • Twitter
    • Uncategorized
    • Vendor Management
    • Vendor Selection
    • Video
    • Web
    • Webinar
    • Wyeth
    • Wyth
  • Add to Technorati Favorites
    Alltop, all the top stories
  • Pages

    • About Impactiviti
    • About Steve Woodruff
    • Contact

Blog at WordPress.com.

Theme: MistyLook by WPThemes.


Follow

Get every new post delivered to your Inbox.

Powered by WordPress.com
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: